LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

Начало・Списък с акции・Avanos Medical Inc

Avanos Medical Inc

Затворен

Сектор Здравеопазване

22.49 -1.58

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

22.37

Максимум

22.71

Ключови измерители
By Trading Economics
Приходи	2.7M 1.8M
Продажби	5.6M 172M
P/E Средно за сектора	60.62 112.16
EPS	0.34
Марж на печалбата	1.048
Служители	3,771
EBITDA	4.6M 21M

Препоръки
By TipRanks
Препоръки	Неутрален
12-месечна прогноза	+4.94 upside

Дивиденти
By Dow Jones
Следващи печалби	30.10.2024 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-36M 1.1B
Предишно отваряне	24.07
Предишно затваряне	22.49

Настроения в новините

By Acuity

50%

148 / 366 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bullish Evidence

22.58 / 23.17 Подкрепа & съпротива

Avanos Medical Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

21.10.2024 г., 23:17 ч. UTC

Топ новини

Australian Consumer Confidence Highest Since Early 2023

21.10.2024 г., 20:42 ч. UTC

Печалби

SAP 3Q Revenue, Profit Climb on AI Demand; Outlook Raised

21.10.2024 г., 22:57 ч. UTC

Печалби

Ping An Insurance: Higher Income From Healthcare, Senior-Care Services Supported Results >2318.HK

21.10.2024 г., 22:57 ч. UTC

Печалби

Ping An Insurance 9-Mos Rev CNY861.8B ; Up 8.7% on Year >2318.HK

21.10.2024 г., 22:57 ч. UTC

Печалби

Ping An Insurance 9-Mos Net CNY119.2B; Up 36.1% on Year >2318.HK

21.10.2024 г., 22:10 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Webjet Looks Like an M&A Target, But Bids Unlikely Soon -- Market Talk

21.10.2024 г., 21:02 ч. UTC

Придобивния, сливания и поглъщания

Sanofi Deal Jitters Imperil Stock's Big Rebound -- Barrons.com

21.10.2024 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

21.10.2024 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

21.10.2024 г., 20:50 ч. UTC

Пазарно говорене

Печалби

Tech, Media & Telecom Roundup: Market Talk

21.10.2024 г., 20:32 ч. UTC

Печалби

Nucor: The Earnings of the Raw Materials Segment Are Expected to Increase in 4Q Compared to 3Q >NUE

21.10.2024 г., 20:31 ч. UTC

Печалби

Nucor: Expect Consolidated Net Earnings Attributable to Nucor Stockholders in 4Q to Decrease >NUE

21.10.2024 г., 20:30 ч. UTC

Печалби

Nucor 3Q Total Tons Shipped to Outside Customers Down 1% >NUE

21.10.2024 г., 20:30 ч. UTC

Печалби

Nucor 3Q Steel Mills Total Shipments 5.72M Tons >NUE

21.10.2024 г., 20:30 ч. UTC

Печалби

Nucor 3Q Average Sales Price Per Ton Down 15% >NUE

21.10.2024 г., 20:30 ч. UTC

Печалби

Nucor 3Q EPS $1.05 >NUE

21.10.2024 г., 20:30 ч. UTC

Печалби

Nucor 3Q Sales $7.44B >NUE

21.10.2024 г., 20:30 ч. UTC

Печалби

Nucor 3Q Net $249.9M >NUE

21.10.2024 г., 20:20 ч. UTC

Придобивния, сливания и поглъщания

Glendon Capital Filing Mentions Reuters Article About Glendon Opposition to Verizon Deal

21.10.2024 г., 20:20 ч. UTC

Топ новини

Nvidia Reaches $3.5 Trillion Market Value. It's Right on Apple's Heels. -- Barrons.com

21.10.2024 г., 20:19 ч. UTC

Придобивния, сливания и поглъщания

Frontier Communications Shareholder Glendon Capital Will Continue to Engage in Talks With Relevant Parties About Sale to Verizon

21.10.2024 г., 20:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

21.10.2024 г., 20:14 ч. UTC

Топ новини

S&P 500, Dow Slip; Bond Yields Rise -- WSJ

21.10.2024 г., 20:10 ч. UTC

Печалби

SAP Backs 2024 Cloud Revenue EUR17B-EUR17.3B >SAP

21.10.2024 г., 20:10 ч. UTC

Печалби

SAP Raises 2024 Cloud and Software Revenue View to EUR29.5B-EUR29.8B >SAP

21.10.2024 г., 20:08 ч. UTC

Печалби

SAP Sees Exiting 2024 at Headcount Slightly Ahead of Year-End 2023 >SAP

21.10.2024 г., 20:07 ч. UTC

Печалби

SAP 3Q Cloud and Software Revenue EUR7.43B >SAP

21.10.2024 г., 20:07 ч. UTC

Печалби

SAP 3Q Software Licenses Revenue EUR280M>SAP

21.10.2024 г., 20:06 ч. UTC

Печалби

SAP 3Q Adj EPS EUR1.23 >SAP

21.10.2024 г., 20:06 ч. UTC

Печалби

SAP 3Q EPS EUR1.25 >SAP

Сравнение с други в отрасъла

Ценова промяна

Avanos Medical Inc Прогноза

Ценова цел

By TipRanks

4.94% нагоре

12-месечна прогноза

Среден 24 USD 4.94%

Висок 24 USD

Нисък 24 USD

Според 2 анализатори от Wall Street, предложили 12-месечна ценова цел за Avanos Medical Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

2 ratings

Купи

Задържане

Продай

Според 2 анализатори, дали борсови рейтинги на Avanos Medical Inc през последните 3 месеца.

Техническа оценка

By Trading Central

22.58 / 23.17Подкрепа & съпротива

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bullish.

Настроение

By Acuity

148 / 366 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Avanos Medical Inc

Avanos Medical, Inc. is a medical technology company, which focused on delivering medical device solutions. The Company develops, manufactures and markets solutions in approximately 90 countries. It provides a portfolio of product offerings focused on chronic care and pain management to improve patient outcomes. Chronic care is a portfolio of products, which include digestive health products, such as its Mic-Key enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as its closed airway suction systems and other airway management devices under the Ballard, Microcuff and Endoclear brands. Pain management is a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems; and Interventional pain solutions, which provides pain relieving therapies, such as its Coolief pain therapy.